drugset
drugset / Trial / NCT00611572

GABA-glutamate Interactions and Psychosis

NCT00611572 ↗

Phase 1 Completed 23 enrolled Yale University National Alliance for Research on Schizophrenia and Depression · collab
RandomizedSingle-groupTriple-blindOther

Summary

This study investigates the interactions between NMDA (N-Methyl-D-aspartic acid) antagonism and GABA (gamma-aminobutyric acid) system as it relates to cognitive function assessed by ERPs (event-related potentials) in healthy volunteers.

Timeline

Start
2007-01
Primary completion
2018-10-02
Completion
2018-10-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iomazenil Small molecule — Intravenous

Indications

cognitive disorder